Variant report
Variant | esv1802073 |
---|---|
Chromosome Location | chr6:79521067-79526269 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:9)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:2)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:9 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | E2F4 | chr6:79522269-79522469 | MCF10A-Er-Src | breast: | n/a | n/a |
2 | GATA2 | chr6:79522643-79523186 | HUVEC | blood vessel: | n/a | n/a |
3 | MAFK | chr6:79521110-79521345 | IMR90 | lung: | n/a | n/a |
4 | MYC | chr6:79519850-79521225 | MCF10A-Er-Src | breast: | n/a | n/a |
5 | POLR2A | chr6:79521525-79521562 | GM12878 | blood: | n/a | n/a |
6 | POLR2A | chr6:79526013-79526030 | MCF10A-Er-Src | breast: | n/a | n/a |
7 | POLR2A | chr6:79524028-79524173 | MCF10A-Er-Src | breast: | n/a | n/a |
8 | STAT3 | chr6:79525384-79525549 | MCF10A-Er-Src | breast: | n/a | n/a |
9 | STAT3 | chr6:79524978-79525070 | MCF10A-Er-Src | breast: | n/a | n/a |
No data |
No data |
(count:2 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-PHIP-1 | chr6:79519432-79521881 | XLOC_005771 |
2 | lnc-PHIP-1 | chr6:79522839-79523020 | XLOC_005771 |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000229495 | TF binding region |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs567623422 | chr6:79521099-79521100 | Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
2 | rs556671925 | chr6:79521139-79521140 | Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
3 | rs186487897 | chr6:79521158-79521159 | Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
4 | rs553305507 | chr6:79521163-79521164 | Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
5 | rs573356757 | chr6:79521187-79521188 | Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
6 | rs190947093 | chr6:79521211-79521212 | Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
7 | rs562795134 | chr6:79521242-79521243 | Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
8 | rs41269337 | chr6:79521269-79521270 | Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
9 | rs183030751 | chr6:79521281-79521282 | Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
10 | rs543438688 | chr6:79521284-79521285 | Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
11 | rs187563363 | chr6:79521293-79521294 | Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
12 | rs573991967 | chr6:79521361-79521362 | Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
13 | rs542881133 | chr6:79521371-79521372 | Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
14 | rs559313042 | chr6:79521374-79521375 | Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
15 | rs537698462 | chr6:79521403-79521404 | Enhancers Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
16 | rs190868410 | chr6:79521435-79521436 | Enhancers Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
17 | rs183005078 | chr6:79521440-79521441 | Enhancers Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
18 | rs565038547 | chr6:79521485-79521486 | Enhancers Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
19 | rs151217944 | chr6:79521494-79521495 | Enhancers Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
20 | rs140448290 | chr6:79521518-79521519 | Enhancers Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
21 | rs188141936 | chr6:79521524-79521525 | Enhancers Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
22 | rs145238985 | chr6:79521558-79521559 | Enhancers Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
23 | rs192146694 | chr6:79521572-79521573 | Enhancers Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
24 | rs375924708 | chr6:79521623-79521624 | Enhancers Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
25 | rs547247832 | chr6:79521627-79521628 | Enhancers Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
26 | rs113498429 | chr6:79521683-79521684 | Enhancers Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
27 | rs574286087 | chr6:79521707-79521708 | Enhancers Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
28 | rs539210709 | chr6:79521712-79521713 | Enhancers Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
29 | rs557614797 | chr6:79521745-79521746 | Enhancers Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
30 | rs577814898 | chr6:79521757-79521758 | Enhancers Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
31 | rs541391926 | chr6:79521774-79521775 | Enhancers Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
32 | rs564868955 | chr6:79521775-79521776 | Enhancers Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
33 | rs537101685 | chr6:79521781-79521782 | Enhancers Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
34 | rs184290068 | chr6:79521797-79521798 | Enhancers Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
35 | rs578120266 | chr6:79521806-79521807 | Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
36 | rs573658395 | chr6:79521825-79521826 | Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
37 | rs377757531 | chr6:79521826-79521827 | Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
38 | rs542591328 | chr6:79521831-79521832 | Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
39 | rs559589028 | chr6:79521862-79521863 | Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
40 | rs573004088 | chr6:79521865-79521866 | Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
41 | rs545194846 | chr6:79521871-79521872 | Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
42 | rs564699147 | chr6:79521889-79521890 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs530929492 | chr6:79521929-79521930 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs187876155 | chr6:79521954-79521955 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs560972342 | chr6:79521975-79521976 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs140870377 | chr6:79521998-79521999 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs547016598 | chr6:79522004-79522005 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs563851004 | chr6:79522054-79522055 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs370921158 | chr6:79522065-79522066 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs375340819 | chr6:79522090-79522091 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Uveal melanoma | 21693616 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Biliary cancer | 19435499 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Malaria | 21533027 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Autism | 21448237 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Autism | 22495311 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Gastric cancer | 17908304 | CNVD |
Biliary cancer | 20360734 | CNVD |
Breast cancer | 20360734 | CNVD |
Coronary artery disease | 20360734 | CNVD |
Crohn''s disease | 20360734 | CNVD |
Hypertension | 20360734 | CNVD |
Rheumatoid arthritis | 20360734 | CNVD |
Type 1 diabetes | 20360734 | CNVD |
Type 2 diabetes | 20360734 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Breast cancer | 17603634 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Systemic lupus erythematosus | 17503323 | CNVD |
Melanoma | 18172304 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Cancer | 21637783 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Acute lymphoblastic leukemia | 17443227 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Follicular lymphoma | 19010834 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Breast cancer | 16608533 | CNVD |
Non-small cell lung cancer | 21385341 | CNVD |
Prostate cancer | 16705090 | CNVD |
Adenoid cystic carcinoma | 17372589 | CNVD |
Ependymoma | 16718352 | CNVD |
High-proliferative meningiomas | 17937814 | CNVD |
Intracranial tumor | 16823260 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Prostate cancer | 16573809 | CNVD |
Breast cancer | 16272173 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Prostate cancer | 18632612 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Urothelial carcinoma | 18382360 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Wilms tumour | 21544195 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
Follicular lymphoma | 17699855 | CNVD |
Breast cancer | 17133270 | CNVD |
Leukemia | 18688285 | CNVD |
Prostate cancer | 19242612 | CNVD |
Developmental delay | 21147756 | CNVD |
Glioma | 21046410 | CNVD |
Primary central nervous system lymphoma | 21088137 | CNVD |
Zellweger syndrome | 21572526 | CNVD |
Follicular lymphoma | 20505157 | CNVD |
Congenital diaphragmatic hernia | 21085971 | CNVD |
Malignant melanoma | 18718029 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Lung adenocarcinoma | 21935476 | CNVD |
Breast cancer | 21364760 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Salivary gland tumor | 18059337 | CNVD |
Lung cancer | 16773561 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Urothelial cell carcinoma | 18451213 | CNVD |
Prostate cancer | 16461572 | CNVD |
Mental retardation | 21045960 | CNVD |
Obesity | 21045960 | CNVD |
learning difficulties | 21045960 | CNVD |
Prostate cancer | 17245344 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Cancer | 20164920 | CNVD |
Burkitt''s lymphoma | 20823134 | CNVD |
Ductal carcinoma | 22052326 | CNVD |
Lung cancer | 18438408 | CNVD |
Breast cancer | 21858162 | CNVD |
Acute lymphoblastic leukemia | 18458336 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr6:79519000-79521800 | Enhancers | HMEC | breast |
2 | chr6:79519200-79521400 | Enhancers | Foreskin Keratinocyte Primary Cells skin02 | Skin |
3 | chr6:79519200-79521800 | Enhancers | Breast Myoepithelial Primary Cells | Breast |
4 | chr6:79519200-79521800 | Enhancers | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
5 | chr6:79519600-79521400 | Enhancers | Foreskin Keratinocyte Primary Cells skin03 | Skin |
6 | chr6:79519800-79521200 | Enhancers | Liver | Liver |
7 | chr6:79519800-79521600 | Enhancers | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
8 | chr6:79520200-79521200 | Enhancers | Osteobl | bone |
9 | chr6:79520400-79521200 | Enhancers | Muscle Satellite Cultured Cells | -- |
10 | chr6:79520600-79521600 | Enhancers | NHEK | skin |
11 | chr6:79521400-79522600 | Weak transcription | Foreskin Keratinocyte Primary Cells skin03 | Skin |
12 | chr6:79521800-79522800 | Weak transcription | HMEC | breast |
13 | chr6:79521800-79527000 | Weak transcription | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
14 | chr6:79522800-79523000 | Enhancers | Foreskin Keratinocyte Primary Cells skin03 | Skin |
15 | chr6:79522800-79523000 | Enhancers | HMEC | breast |